Drug makers are just beginning to realize how collaboration and communication networks can improve business processes. But what seems like a spoon full of sugar is often a tough pill to swallow when you consider regulatory requirements from agencies like the FDA for use of these networks. This white paper provides an understanding of many of the regulatory and legal issues related to electronic communications and social media in the pharmaceutical industry.
Read this paper to gain an understanding of:
• What the regulatory landscape of the pharmaceuticals industry looks like
• What concerns you should be aware of from a legal perspective
Download this free white paper now - Click Here
Provided by: Actiance
Posts
0 comments:
Post a Comment